Efficacy of Candesartan on Symptomatic Heart Failure in Treating Diabetic and Hypertensive Patients.
Status:
Completed
Trial end date:
2008-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the effects of candesartan, once daily (QD), on the
N-terminal pro-B-type Natriuretic Peptide laboratory marker in subjects with symptomatic
heart failure with diastolic dysfunction.